# The Kansas Institute for Precision Medicine

> **NIH NIH P20** · UNIVERSITY OF KANSAS MEDICAL CENTER · 2024 · $2,337,371

## Abstract

ABSTRACT
The Kansas Institute for Precision Medicine (KIPM) fosters medical advancements by facilitating the next
generation of basic and physician-scientists, shaping their research ideas with a
precision medicine
focus, and
making them highly competitive for national peer-reviewed funding. The KIPM Phase 2 COBRE will continue our
successful efforts to train the next generation of translational research leaders in areas such as education,
research, and healthcare. The KIPM has become a major pillar of the University of Kansas Medical Center
(KUMC) and region by raising awareness and advancing precision medicine efforts to transform healthcare for
patients suffering from various disease states. To continue our mission, we propose the following Specific Aims:
1. Recruit and mentor outstanding junior investigators in diverse research disciplines focused on advancing
precision medicine to improve patient outcomes. In a rigorous pre-selection process, four promising junior
investigators, i.e., Research Project Leaders (RPLs), were selected from over a dozen applicants all of which
had a research theme directly related to precision medicine. Decisions were based on the content of research
proposals and training potential that were evaluated by our leadership team, including the three PIs of the
proposed COBRE and current External Advisory Committee members. Each applicant has identified at least two
internal and one external mentor with expertise related to their area of study. All Phase 2 COBRE RPL candidates
contributed to discussions regarding infrastructure necessary to enhance their projects via one-on-one meetings
with the PIs and Research Core leaders to help shape infrastructure needs to enhance their research capacity.
2. Evolve the established organizational structure and institutional support to realize a cohesive and sustainable
program in precision medicine at KUMC. The administrative structure for the KIPM Phase 2 COBRE will be
facilitated by a multi-PI leadership of 3 seasoned researchers with complementary expertise and the additional
expertise afforded by a newly formed Advisory Committee. Continued institutional support of over $1M annually,
including expanded pilot grant funding, will help sustain and advance the KIPM’s mission to improve patient
outcomes by training physicians/scientists in precision medicine. 3. Enhance basic and translational research
with a precision medicine theme through a strong research core infrastructure. Three research cores, i.e.,
Biomedical Engineering (BME), Biobanking and Biomarker Validation (BBV), and Quantitative ‘OmiCs’ (QOC)
Cores, will support RPLs and the Pilot Projects Program (PPP) as well as serve the extended research
community in Kansas and beyond. Unique to the KIPM is patient engagement through our established Patient
and Community Engagement (PACE) resource, which provides ‘just-in-time’ mentorship to COBRE RPLs and a
broad range of researchers, emphasizing how to partner and communicat...

## Key facts

- **NIH application ID:** 10849359
- **Project number:** 2P20GM130423-06
- **Recipient organization:** UNIVERSITY OF KANSAS MEDICAL CENTER
- **Principal Investigator:** ANDREW K. GODWIN
- **Activity code:** P20 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $2,337,371
- **Award type:** 2
- **Project period:** 2019-02-15 → 2029-03-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10849359

## Citation

> US National Institutes of Health, RePORTER application 10849359, The Kansas Institute for Precision Medicine (2P20GM130423-06). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10849359. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*